FDA Inspection 808237 — Agila Corporation
The FDA completed an inspection of Agila Corporation on November 8, 2012 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 8, 2012
- Fiscal Year
- 2013
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Minneapolis, MN (United States)